"chemotherapy by doxorubicin" trang 5 - tải miễn phí từ tailieunhanh
Low lean mass and chemotherapy toxicity risk in the elderly: The Fraction study protocol

Low lean mass and chemotherapy toxicity risk in the elderly: The Fraction study protocol
8    70    0
A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer

A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer
9    85    0
ACRNaCT trial protocol: Efficacy of adjuvant chemotherapy in patients with clinical T3b/ T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: A pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial

ACRNaCT trial protocol: Efficacy of adjuvant chemotherapy in patients with clinical T3b/ T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: A pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
7    75    0
Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: Long-term oncological outcome analysis in 37 Chinese hospitals

Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: Long-term oncological outcome analysis in 37 Chinese hospitals
10    96    0
Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
8    65    0
Study of haematological parameters in pre and post-treated dogs with chemotherapy by doxorubicin and vincristine in canine transmissible venereal tumour

Study of haematological parameters in pre and post-treated dogs with chemotherapy by doxorubicin and vincristine in canine transmissible venereal tumour
6    88    0
Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: A Japanese realworld cohort study

Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: A Japanese realworld cohort study
10    56    0
Predicting the response to neoadjuvant chemotherapy for breast cancer: Wavelet transforming radiomics in MRI

Predicting the response to neoadjuvant chemotherapy for breast cancer: Wavelet transforming radiomics in MRI
10    74    0
Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
10    54    0
GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: Their correlation with therapeutic outcome of neoadjuvant chemotherapy

GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: Their correlation with therapeutic outcome of neoadjuvant chemotherapy
12    102    0
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
11    66    0
Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer

Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
7    63    0
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immunehistochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIrB/FOx regimen: An experience of multidisciplinary management in clinical practice

Poorly differentiated neuroendocrine rectal carcinoma with uncommon immunehistochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIrB/FOx regimen: An experience of multidisciplinary management in clinical practice
10    77    0
Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age

Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age
8    68    0
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review

Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review
7    60    0
Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neoadjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neoadjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol
10    95    0
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer

Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
10    110    0
Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy

Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy
15    85    0
Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: A propensity-matched analysis

Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: A propensity-matched analysis
9    74    0
No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
11    98    0